Why biotech startup Tenvie sees promise in drugs from founders' old company
About a year ago, Tenvie President and Chief Scientific Officer Tony Estrada approached Denali CEO Ryan Watts and others in ...
Outsourcing-pharma2d
Denali Therapeutics’ ALS drug fails to improve function and survival in phase 2/3 trial
Denali Therapeutics' DNL343 fails to slow ALS progression in phase 2/3 trial but shows safety and offers insights for future ...
Denali Therapeutics Announces Topline Results for Regimen G Evaluating eIF2B Agonist DNL343 in the Phase 2/3 HEALEY ALS Platform Trial
Primary endpoint of overall function (ALSFRS-R) and survival, and key secondary endpoints of muscle strength and respiratory function, were not ...
ALS News Today20h
DNL343, fosigotifator fail HEALEY platform trial’s main goal in ALS
DNL343 and fosigotifator are made to activate the ISR pathway protein eIF2B, but both failed to slow ALS progression in the ...
Yahoo Finance6d
Denali Therapeutics Neurodegenerative Disease Platform Sparks Analyst Optimistic
Most recently, Denali Therapeutics initiated dosing in a global BEACON Phase 2a trial of BIIB122 (DNL151) for LRRK2-associated Parkinson’s disease. Denali’s market cap stands at $2.93 billion ...
Alaska Dispatch News4d
Opinion: We don’t need a vote to know Alaskans have long preferred Denali over McKinley
The pre-European contact Koyukon Athabaskan locals called it Denali or Dinale, translated to “the high one.” The Cook Inlet Dena’ina Athabaskans used Dghelay Ka’a, meaning “the big ...
ETF Daily News6d
Denali Therapeutics Inc. (NASDAQ:DNLI) Director Vicki L. Sato Sells 3,080 Shares of Stock
Denali Therapeutics Inc. has a 12 month low of $14.56 and a 12 month high of $33.33. Get Denali Therapeutics alerts: Denali Therapeutics (NASDAQ:DNLI – Get Free Report) last released its ...
Yahoo Finance6d
Denali Therapeutics Neurodegenerative Disease Platform Sparks Analyst Optimistic
William Blair has initiated coverage on Denali Therapeutics Inc (NASDAQ:DNLI), a company focused on developing drugs for neurodegenerative diseases. The analyst highlights that Denali is developing a ...
Fairbanks Daily News-Miner5d
Denali Bancorporation increases dividend to $0.85 per share
Denali Bancorporation, Inc., the parent company of Denali State Bank, announced a $0.05 increase in its quarterly cash dividend, raising it to $0.85 per share. The dividend will be payable on Jan ...
Yahoo Finance3d
Denali Capital Acquisition Corp. (DECA)
NEW YORK, NEW YORK, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that it has deposited into the Company’s trust account ...
Alaska Dispatch News5d
Opinion: Are we really having another conversation about Denali vs. McKinley?
Denali was visible from Point Woronzof in Anchorage on Wednesday, Oct. 9, 2024, as a person rides a bicycle on the Tony Knowles Coastal Trail. (Bill Roth / ADN) I guess it makes sense that a ...
Investing6d
Denali Therapeutics Inc (DNLI)
Denali Therapeutics (NASDAQ:DNLI) Inc. has reached a new 52-week high, with its stock price climbing to $32.17. This milestone reflects a significant surge in investor ...